210 related articles for article (PubMed ID: 16820297)
1. Shape-shifting serpins--advantages of a mobile mechanism.
Huntington JA
Trends Biochem Sci; 2006 Aug; 31(8):427-35. PubMed ID: 16820297
[TBL] [Abstract][Full Text] [Related]
2. Crystal structures of native and thrombin-complexed heparin cofactor II reveal a multistep allosteric mechanism.
Baglin TP; Carrell RW; Church FC; Esmon CT; Huntington JA
Proc Natl Acad Sci U S A; 2002 Aug; 99(17):11079-84. PubMed ID: 12169660
[TBL] [Abstract][Full Text] [Related]
3. What do dysfunctional serpins tell us about molecular mobility and disease?
Stein PE; Carrell RW
Nat Struct Biol; 1995 Feb; 2(2):96-113. PubMed ID: 7749926
[TBL] [Abstract][Full Text] [Related]
4. Thrombin inhibition by the serpins.
Huntington JA
J Thromb Haemost; 2013 Jun; 11 Suppl 1():254-64. PubMed ID: 23809129
[TBL] [Abstract][Full Text] [Related]
5. Serpins: the uncut version.
Goldsmith EJ; Mottonen J
Structure; 1994 Apr; 2(4):241-4. PubMed ID: 8087550
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory mechanism of serpins. Identification of steps involving the active-site serine residue of the protease.
Stone SR; Le Bonniec BF
J Mol Biol; 1997 Jan; 265(3):344-62. PubMed ID: 9018048
[TBL] [Abstract][Full Text] [Related]
7. Preparative induction and characterization of L-antithrombin: a structural homologue of latent plasminogen activator inhibitor-1.
Wardell MR; Chang WS; Bruce D; Skinner R; Lesk AM; Carrell RW
Biochemistry; 1997 Oct; 36(42):13133-42. PubMed ID: 9335576
[TBL] [Abstract][Full Text] [Related]
8. How serpins change their fold for better and for worse.
Carrell RW; Huntington JA
Biochem Soc Symp; 2003; (70):163-78. PubMed ID: 14587291
[TBL] [Abstract][Full Text] [Related]
9. General features of the heparin-binding serpins antithrombin, heparin cofactor II and protein C inhibitor.
Pratt CW; Church FC
Blood Coagul Fibrinolysis; 1993 Jun; 4(3):479-90. PubMed ID: 8392392
[TBL] [Abstract][Full Text] [Related]
10. Antiangiogenic function of antithrombin is dependent on its conformational variation: implication for other serpins.
Azhar A; Singh P; Rashid Q; Naseem A; Khan MS; Jairajpuri MA
Protein Pept Lett; 2013 Apr; 20(4):403-11. PubMed ID: 23016581
[TBL] [Abstract][Full Text] [Related]
11. Serpin structure, function and dysfunction.
Huntington JA
J Thromb Haemost; 2011 Jul; 9 Suppl 1():26-34. PubMed ID: 21781239
[TBL] [Abstract][Full Text] [Related]
12. Serpin-glycosaminoglycan interactions.
Rein CM; Desai UR; Church FC
Methods Enzymol; 2011; 501():105-37. PubMed ID: 22078533
[TBL] [Abstract][Full Text] [Related]
13. Modeling of serpin-protease complexes: antithrombin-thrombin, alpha 1-antitrypsin (358Met-->Arg)-thrombin, alpha 1-antitrypsin (358Met-->Arg)-trypsin, and antitrypsin-elastase.
Whisstock J; Lesk AM; Carrell R
Proteins; 1996 Nov; 26(3):288-303. PubMed ID: 8953650
[TBL] [Abstract][Full Text] [Related]
14. Biological implications of a 3 A structure of dimeric antithrombin.
Carrell RW; Stein PE; Fermi G; Wardell MR
Structure; 1994 Apr; 2(4):257-70. PubMed ID: 8087553
[TBL] [Abstract][Full Text] [Related]
15. Homozygous deficiency of heparin cofactor II: relevance of P17 glutamate residue in serpins, relationship with conformational diseases, and role in thrombosis.
Corral J; Aznar J; Gonzalez-Conejero R; Villa P; Miñano A; Vayá A; Carrell RW; Huntington JA; Vicente V
Circulation; 2004 Sep; 110(10):1303-7. PubMed ID: 15337701
[TBL] [Abstract][Full Text] [Related]
16. Understanding the specificity of serpin-protease complexes through interface analysis.
Rashid Q; Kapil C; Singh P; Kumari V; Jairajpuri MA
J Biomol Struct Dyn; 2015; 33(6):1352-62. PubMed ID: 25052369
[TBL] [Abstract][Full Text] [Related]
17. Interaction of thrombin with antithrombin, heparin cofactor II, and protein C inhibitor.
Whinna HC; Church FC
J Protein Chem; 1993 Dec; 12(6):677-88. PubMed ID: 8136018
[TBL] [Abstract][Full Text] [Related]
18. Serpins. A mechanistic class of their own.
Stone SR; Whisstock JC; Bottomley SP; Hopkins PC
Adv Exp Med Biol; 1997; 425():5-15. PubMed ID: 9433485
[No Abstract] [Full Text] [Related]
19. Factors with conformational effects on haemostatic serpins: implications in thrombosis.
Hernández-Espinosa D; Ordóñez A; Vicente V; Corral J
Thromb Haemost; 2007 Sep; 98(3):557-63. PubMed ID: 17849043
[TBL] [Abstract][Full Text] [Related]
20. Conformational changes in serpins: II. The mechanism of activation of antithrombin by heparin.
Whisstock JC; Pike RN; Jin L; Skinner R; Pei XY; Carrell RW; Lesk AM
J Mol Biol; 2000 Sep; 301(5):1287-305. PubMed ID: 10966821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
